GE HealthCare Exceeds Quarterly Profit Estimates Amid Strong Imaging Demand and Tariff Refunds
GE HealthCare reported second-quarter net income of $561 million, surpassing Wall Street estimates due to strong demand for its imaging devices and refunds from previously imposed U.S. tariffs under former President Donald Trump. The company's revenue reached $5.30 billion, with notable growth in the imaging device segment (7.9%) and pharmaceutical diagnostics (15.6%). Adjusted earnings per share came in at $1.13 versus an expected $1.04. Despite rising costs from inflationary pressures on memory chips, oil, and freight, GE HealthCare maintained its annual profit forecast. The company cited global geopolitical instability as a factor affecting supply chains and logistics during the quarter. Shares of the firm rose 12% in premarket trading.
Tickers: $ABT $GEHC $HCA $ISRG $JNJ
Topics: medical_devices profit_growth tariffs